Related to the disease risk of CLL, there was a statistically significant association between the Binet stages and the Hb categories (Table 7). Stages with a high risk of the disease (stage C) appear significantly more often in patients with low Hb values. Here, GSTM1 is linked to B-cell chronic lymphocytic leukemia.